Cargando…

Human Engineered Heart Tissue: Analysis of Contractile Force

Analyzing contractile force, the most important and best understood function of cardiomyocytes in vivo is not established in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM). This study describes the generation of 3D, strip-format, force-generating engineered heart tissues (EHT)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mannhardt, Ingra, Breckwoldt, Kaja, Letuffe-Brenière, David, Schaaf, Sebastian, Schulz, Herbert, Neuber, Christiane, Benzin, Anika, Werner, Tessa, Eder, Alexandra, Schulze, Thomas, Klampe, Birgit, Christ, Torsten, Hirt, Marc N., Huebner, Norbert, Moretti, Alessandra, Eschenhagen, Thomas, Hansen, Arne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944531/ https://www.ncbi.nlm.nih.gov/pubmed/27211213 http://dx.doi.org/10.1016/j.stemcr.2016.04.011

Ejemplares similares

Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart Tissue
por: Jacob, Fabian, et al.
Publicado: (2016)

Correction: Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart Tissue
por: Jacob, Fabian, et al.
Publicado: (2018)

Ca(2+)-Currents in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Effects of Two Different Culture Conditions
por: Uzun, Ahmet U., et al.
Publicado: (2016)

Human iPSC-derived cardiomyocytes cultured in 3D engineered heart tissue show physiological upstroke velocity and sodium current density
por: Lemoine, Marc D., et al.
Publicado: (2017)

Low Resting Membrane Potential and Low Inward Rectifier Potassium Currents Are Not Inherent Features of hiPSC-Derived Cardiomyocytes
por: Horváth, András, et al.
Publicado: (2018)

Phosphomimetic cardiac myosin-binding protein C partially rescues a cardiomyopathy phenotype in murine engineered heart tissue
por: Dutsch, Alexander, et al.
Publicado: (2019)

Regulation of I(Ca,L) and force by PDEs in human‐induced pluripotent stem cell‐derived cardiomyocytes
por: Saleem, Umber, et al.
Publicado: (2020)

Contractile Work Contributes to Maturation of Energy Metabolism in hiPSC-Derived Cardiomyocytes
por: Ulmer, Bärbel M., et al.
Publicado: (2018)

Blinded Contractility Analysis in hiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial Trabeculae
por: Mannhardt, Ingra, et al.
Publicado: (2017)

Effects of proarrhythmic drugs on relaxation time and beating pattern in rat engineered heart tissue
por: Eder, Alexandra, et al.
Publicado: (2014)

Increased afterload induces pathological cardiac hypertrophy: a new in vitro model
por: Hirt, Marc N., et al.
Publicado: (2012)

Clonal dynamics studied in cultured induced pluripotent stem cells reveal major growth imbalances within a few weeks
por: Brenière-Letuffe, David, et al.
Publicado: (2018)

Force and Calcium Transients Analysis in Human Engineered Heart Tissues Reveals Positive Force-Frequency Relation at Physiological Frequency
por: Saleem, Umber, et al.
Publicado: (2020)

Satellite cells delivered in their niche efficiently generate functional myotubes in three-dimensional cell culture
por: Prüller, Johanna, et al.
Publicado: (2018)

Sulforaphane exposure impairs contractility and mitochondrial function in three-dimensional engineered heart tissue
por: Rhoden, Alexandra, et al.
Publicado: (2021)

Guanabenz Interferes with ER Stress and Exerts Protective Effects in Cardiac Myocytes
por: Neuber, Christiane, et al.
Publicado: (2014)

Case Report on: Very Early Afterdepolarizations in HiPSC-Cardiomyocytes—An Artifact by Big Conductance Calcium Activated Potassium Current (I(bk,Ca))
por: Horváth, András, et al.
Publicado: (2020)

Blinded, Multicenter Evaluation of Drug-induced Changes in Contractility Using Human-induced Pluripotent Stem Cell-derived Cardiomyocytes
por: Saleem, Umber, et al.
Publicado: (2020)

Single‐Cell Transcriptomics of Engineered Cardiac Tissues From Patient‐Specific Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Abnormal Developmental Trajectory and Intrinsic Contractile Defects in Hypoplastic Right Heart Syndrome
por: Lam, Yin‐Yu, et al.
Publicado: (2020)

Human Engineered Heart Tissue as a Versatile Tool in Basic Research and Preclinical Toxicology
por: Schaaf, Sebastian, et al.
Publicado: (2011)

Prominent differences in left ventricular performance and myocardial properties between right ventricular and left ventricular-based pacing modes in rats
por: Mulla, Wesam, et al.
Publicado: (2017)

Recapitulation of dyssynchrony-associated contractile impairment in asymmetrically paced engineered heart tissue
por: Stenzig, Justus, et al.
Publicado: (2022)

Comparison of 10 Control hPSC Lines for Drug Screening in an Engineered Heart Tissue Format
por: Mannhardt, Ingra, et al.
Publicado: (2020)

Towards a Tissue-Engineered Contractile Fontan-Conduit: The Fate of Cardiac Myocytes in the Subpulmonary Circulation
por: Biermann, Daniel, et al.
Publicado: (2016)

An Important Role for DNMT3A-Mediated DNA Methylation in Cardiomyocyte Metabolism and Contractility
por: Madsen, Alexandra, et al.
Publicado: (2020)

Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits
por: Smith, James G.W., et al.
Publicado: (2018)

Human model of primary carnitine deficiency cardiomyopathy reveals ferroptosis as a novel mechanism
por: Loos, Malte, et al.
Publicado: (2023)

Effects of the Delta Opioid Receptor Agonist DADLE in a Novel Hypoxia-Reoxygenation Model on Human and Rat-Engineered Heart Tissue: A Pilot Study
por: Funcke, Sandra, et al.
Publicado: (2020)

Blockade of miR-140-3p prevents functional deterioration in afterload-enhanced engineered heart tissue
por: Werner, Tessa R., et al.
Publicado: (2019)

Human Engineered Heart Tissue Patches Remuscularize the Injured Heart in a Dose-Dependent Manner
por: Querdel, Eva, et al.
Publicado: (2021)

Contractile Force of Transplanted Cardiomyocytes Actively Supports Heart Function After Injury
por: Stüdemann, Tim, et al.
Publicado: (2022)

Development of Long Noncoding RNA-Based Strategies to Modulate Tissue Vascularization
por: Fiedler, Jan, et al.
Publicado: (2015)

CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy
por: Mosqueira, Diogo, et al.
Publicado: (2018)

Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?
por: Christ, Torsten, et al.
Publicado: (2021)

Impairment of the ER/mitochondria compartment in human cardiomyocytes with PLN p.Arg14del mutation
por: Cuello, Friederike, et al.
Publicado: (2021)

Correction: Common MicroRNA Signatures in Cardiac Hypertrophic and Atrophic Remodeling Induced by Changes in Hemodynamic Load
por: El-Armouche, Ali, et al.
Publicado: (2011)

Common MicroRNA Signatures in Cardiac Hypertrophic and Atrophic Remodeling Induced by Changes in Hemodynamic Load
por: El-Armouche, Ali, et al.
Publicado: (2010)

Human iPS cell-derived engineered heart tissue does not affect ventricular arrhythmias in a guinea pig cryo-injury model
por: Pecha, Simon, et al.
Publicado: (2019)

Human induced pluripotent stem cell-derived cardiomyocytes as an electrophysiological model: Opportunities and challenges—The Hamburg perspective
por: Ismaili, Djemail, et al.
Publicado: (2023)

Characterization of the PLN p.Arg14del Mutation in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Badone, Beatrice, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_83mqik49bgipn5uamj1r72rvnp